Sami Ullah Mumtaz

Potential Clinical Benefits of Quercetin in the Early Stage of COVID-19: Results of a Second, Pilot, Randomized, Controlled and Open-Label Clinical Trial

Francesco Di Pierro, Somia Iqtadar, Amjad Khan et al. · International Journal of General Medicine · 2021 · 177 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Oral Co-Supplementation of Curcumin, Quercetin, and Vitamin D3 as an Adjuvant Therapy for Mild to Moderate Symptoms of COVID-19—Results From a Pilot Open-Label, Randomized Controlled Trial

Amjad Khan, Somia Iqtadar, Sami Ullah Mumtaz et al. · Frontiers in Pharmacology · 2022 · 54 citations · Full text

Medicine, Infectious Diseases, Pharmacology +15

Quercetin as a possible complementary agent for early-stage COVID-19: Concluding results of a randomized clinical trial

Francesco Di Pierro, Amjad Khan, Somia Iqtadar et al. · Frontiers in Pharmacology · 2023 · 54 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +15

Clinical Effects of Streptococcus salivarius K12 in Hospitalized COVID-19 Patients: Results of a Preliminary Study

Francesco Di Pierro, Somia Iqtadar, Sami Ullah Mumtaz et al. · Microorganisms · 2022 · 26 citations · Full text

Dentistry, Immunology, Infectious Diseases +15

Vitamin D Deficiency (VDD) and Susceptibility towards Severe Dengue Fever—A Prospective Cross-Sectional Study of Hospitalized Dengue Fever Patients from Lahore, Pakistan

Somia Iqtadar, Amjad Khan, Sami Ullah Mumtaz et al. · Tropical Medicine and Infectious Disease · 2023 · 18 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17